Supplementary Figure S1 from Preclinical Evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer
crossref(2024)
摘要
OC cells are highly sensitive to NTX301 treatment.
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
crossref(2024)
OC cells are highly sensitive to NTX301 treatment.